Morgan Stanley’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $760K | Sell |
837,463
-131,318
| -14% | -$119K | ﹤0.01% | 5247 |
|
2025
Q1 | $438K | Buy |
968,781
+308,720
| +47% | +$139K | ﹤0.01% | 5390 |
|
2024
Q4 | $332K | Sell |
660,061
-188,230
| -22% | -$94.6K | ﹤0.01% | 5587 |
|
2024
Q3 | $768K | Buy |
848,291
+321,662
| +61% | +$291K | ﹤0.01% | 5192 |
|
2024
Q2 | $525K | Buy |
526,629
+67,932
| +15% | +$67.7K | ﹤0.01% | 5273 |
|
2024
Q1 | $679K | Sell |
458,697
-496,435
| -52% | -$735K | ﹤0.01% | 5170 |
|
2023
Q4 | $1.04M | Buy |
955,132
+677,316
| +244% | +$738K | ﹤0.01% | 5270 |
|
2023
Q3 | $328K | Buy |
277,816
+125,587
| +82% | +$148K | ﹤0.01% | 5352 |
|
2023
Q2 | $215K | Sell |
152,229
-153,891
| -50% | -$217K | ﹤0.01% | 5621 |
|
2023
Q1 | $459K | Buy |
306,120
+174,327
| +132% | +$261K | ﹤0.01% | 5303 |
|
2022
Q4 | $154K | Buy |
131,793
+69,231
| +111% | +$81K | ﹤0.01% | 5776 |
|
2022
Q3 | $70K | Sell |
62,562
-66,343
| -51% | -$74.2K | ﹤0.01% | 6247 |
|
2022
Q2 | $203K | Sell |
128,905
-115,250
| -47% | -$181K | ﹤0.01% | 5884 |
|
2022
Q1 | $376K | Sell |
244,155
-284,402
| -54% | -$438K | ﹤0.01% | 5573 |
|
2021
Q4 | $1.3M | Buy |
528,557
+403,214
| +322% | +$988K | ﹤0.01% | 4895 |
|
2021
Q3 | $316K | Sell |
125,343
-3,419
| -3% | -$8.62K | ﹤0.01% | 5749 |
|
2021
Q2 | $367K | Buy |
128,762
+18,235
| +16% | +$52K | ﹤0.01% | 5712 |
|
2021
Q1 | $259K | Sell |
110,527
-19,143
| -15% | -$44.9K | ﹤0.01% | 5504 |
|
2020
Q4 | $228K | Buy |
129,670
+76,287
| +143% | +$134K | ﹤0.01% | 5527 |
|
2020
Q3 | $50K | Sell |
53,383
-31,163
| -37% | -$29.2K | ﹤0.01% | 5725 |
|
2020
Q2 | $73K | Buy |
84,546
+26,198
| +45% | +$22.6K | ﹤0.01% | 5535 |
|
2020
Q1 | $48K | Sell |
58,348
-138,976
| -70% | -$114K | ﹤0.01% | 5476 |
|
2019
Q4 | $175K | Buy |
197,324
+119,302
| +153% | +$106K | ﹤0.01% | 5466 |
|
2019
Q3 | $76K | Buy |
78,022
+31,143
| +66% | +$30.3K | ﹤0.01% | 5541 |
|
2019
Q2 | $51K | Sell |
46,879
-18,584
| -28% | -$20.2K | ﹤0.01% | 5595 |
|
2019
Q1 | $85K | Sell |
65,463
-115,991
| -64% | -$151K | ﹤0.01% | 5463 |
|
2018
Q4 | $166K | Sell |
181,454
-46,700
| -20% | -$42.7K | ﹤0.01% | 5356 |
|
2018
Q3 | $469K | Sell |
228,154
-48,933
| -18% | -$101K | ﹤0.01% | 5040 |
|
2018
Q2 | $499K | Buy |
277,087
+1,990
| +0.7% | +$3.58K | ﹤0.01% | 5098 |
|
2018
Q1 | $648K | Sell |
275,097
-18,315
| -6% | -$43.1K | ﹤0.01% | 4842 |
|
2017
Q4 | $552K | Buy |
293,412
+107,495
| +58% | +$202K | ﹤0.01% | 4919 |
|
2017
Q3 | $461K | Buy |
185,917
+71,593
| +63% | +$178K | ﹤0.01% | 4925 |
|
2017
Q2 | $315K | Sell |
114,324
-54,585
| -32% | -$150K | ﹤0.01% | 5080 |
|
2017
Q1 | $509K | Sell |
168,909
-69,739
| -29% | -$210K | ﹤0.01% | 4826 |
|
2016
Q4 | $754K | Buy |
238,648
+215,322
| +923% | +$680K | ﹤0.01% | 4664 |
|
2016
Q3 | $80K | Buy |
23,326
+11,281
| +94% | +$38.7K | ﹤0.01% | 5400 |
|
2016
Q2 | $28K | Buy |
12,045
+7,290
| +153% | +$16.9K | ﹤0.01% | 5735 |
|
2016
Q1 | $12K | Sell |
4,755
-23,190
| -83% | -$58.5K | ﹤0.01% | 6082 |
|
2015
Q4 | $92K | Buy |
27,945
+10,095
| +57% | +$33.2K | ﹤0.01% | 5452 |
|
2015
Q3 | $43K | Sell |
17,850
-88,803
| -83% | -$214K | ﹤0.01% | 5791 |
|
2015
Q2 | $313K | Buy |
106,653
+60,570
| +131% | +$178K | ﹤0.01% | 4995 |
|
2015
Q1 | $185K | Sell |
46,083
-81,674
| -64% | -$328K | ﹤0.01% | 5252 |
|
2014
Q4 | $384K | Sell |
127,757
-96,913
| -43% | -$291K | ﹤0.01% | 4866 |
|
2014
Q3 | $570K | Sell |
224,670
-88,184
| -28% | -$224K | ﹤0.01% | 4481 |
|
2014
Q2 | $770K | Sell |
312,854
-5,467
| -2% | -$13.5K | ﹤0.01% | 4264 |
|
2014
Q1 | $845K | Buy |
318,321
+196,106
| +160% | +$521K | ﹤0.01% | 4137 |
|
2013
Q4 | $355K | Buy |
122,215
+84,267
| +222% | +$245K | ﹤0.01% | 4705 |
|
2013
Q3 | $116K | Buy |
37,948
+20,266
| +115% | +$61.9K | ﹤0.01% | 5056 |
|
2013
Q2 | $57K | Buy |
+17,682
| New | +$57K | ﹤0.01% | 5184 |
|